These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 23386702)

  • 1. Reversible inhibition of human carboxylesterases by acyl glucuronides.
    Inoue NR; Hall A; Lai WG; Williams ET
    Drug Metab Dispos; 2013 Apr; 41(4):698-703. PubMed ID: 23386702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stereospecific pH-dependent degradation kinetics of R- and S-naproxen-beta-l-O-acyl-glucuronide.
    Mortensen RW; Sidelmann UG; Tjørnelund J; Hansen SH
    Chirality; 2002 May; 14(4):305-12. PubMed ID: 11968070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening of 16 major drug glucuronides for time-dependent inhibition of nine drug-metabolizing CYP enzymes - detailed studies on CYP3A inhibitors.
    Kahma H; Paludetto MN; Neuvonen M; Kurkela M; Filppula AM; Niemi M; Backman JT
    Eur J Pharm Sci; 2024 Jul; 198():106735. PubMed ID: 38423227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NMR spectroscopic studies on the in vitro acyl glucuronide migration kinetics of Ibuprofen ((+/-)-(R,S)-2-(4-isobutylphenyl) propanoic acid), its metabolites, and analogues.
    Johnson CH; Wilson ID; Harding JR; Stachulski AV; Iddon L; Nicholson JK; Lindon JC
    Anal Chem; 2007 Nov; 79(22):8720-7. PubMed ID: 17944439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. S-naproxen-beta-1-O-acyl glucuronide degradation kinetic studies by stopped-flow high-performance liquid chromatography-1H NMR and high-performance liquid chromatography-UV.
    Mortensen RW; Corcoran O; Cornett C; Sidelmann UG; Lindon JC; Nicholson JK; Hansen SH
    Drug Metab Dispos; 2001 Apr; 29(4 Pt 1):375-80. PubMed ID: 11259319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of physicochemical properties on the reactivity and stability of acyl glucuronides
    Camilleri P; Buch A; Soldo B; Hutt AJ
    Xenobiotica; 2018 Sep; 48(9):958-972. PubMed ID: 28967291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of human serum albumin with the electrophilic metabolite 1-O-gemfibrozil-beta-D-glucuronide.
    Sallustio BC; Fairchild BA; Pannall PR
    Drug Metab Dispos; 1997 Jan; 25(1):55-60. PubMed ID: 9010630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of degradation pathways and kinetics of acyl glucuronides by NMR spectroscopy.
    Walker GS; Atherton J; Bauman J; Kohl C; Lam W; Reily M; Lou Z; Mutlib A
    Chem Res Toxicol; 2007 Jun; 20(6):876-86. PubMed ID: 17536843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HPLC/1H NMR spectroscopic studies of the reactive alpha-1-O-acyl isomer formed during acyl migration of S-naproxen beta-1-O-acyl glucuronide.
    Corcoran O; Mortensen RW; Hansen SH; Troke J; Nicholson JK
    Chem Res Toxicol; 2001 Oct; 14(10):1363-70. PubMed ID: 11599927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of 1-beta-O-acyl glucuronides of diclofenac, mefenamic acid and (S)-naproxen by the chemo-selective enzymatic removal of protecting groups from the corresponding methyl acetyl derivatives.
    Baba A; Yoshioka T
    Org Biomol Chem; 2006 Sep; 4(17):3303-10. PubMed ID: 17036119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A New Rapid In Vitro Assay for Assessing Reactivity of Acyl Glucuronides.
    Zhong S; Jones R; Lu W; Schadt S; Ottaviani G
    Drug Metab Dispos; 2015 Nov; 43(11):1711-7. PubMed ID: 26276581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycerolysis of acyl glucuronides as an artifact of in vitro drug metabolism incubations.
    Obach RS
    Drug Metab Dispos; 2009 Aug; 37(8):1581-6. PubMed ID: 19439485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of selected therapeutic agents as inhibitors of carboxylesterase 1: potential sources of metabolic drug interactions.
    Zhu HJ; Appel DI; Peterson YK; Wang Z; Markowitz JS
    Toxicology; 2010 Apr; 270(2-3):59-65. PubMed ID: 20097249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies to further investigate the inhibition of human liver microsomal CYP2C8 by the acyl-β-glucuronide of gemfibrozil.
    Jenkins SM; Zvyaga T; Johnson SR; Hurley J; Wagner A; Burrell R; Turley W; Leet JE; Philip T; Rodrigues AD
    Drug Metab Dispos; 2011 Dec; 39(12):2421-30. PubMed ID: 21911547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of proliferation of HT-29 colon adenocarcinoma cells by carboxylate NSAIDs and their acyl glucuronides.
    Cannell GR; Vesey DA; Dickinson RG
    Life Sci; 2001 Nov; 70(1):37-48. PubMed ID: 11764005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the chemical reactivity of 2-phenylpropionic acid 1-O-acyl glucuronide and S-acyl-CoA thioester metabolites.
    Li C; Benet LZ; Grillo MP
    Chem Res Toxicol; 2002 Oct; 15(10):1309-17. PubMed ID: 12387630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural characterization of anti-HIV drug candidate PA-457 [3-O-(3',3'-dimethylsuccinyl)-betulinic acid] and its acyl glucuronides in rat bile and evaluation of in vitro stability in human and animal liver microsomes and plasma.
    Wen Z; Stern ST; Martin DE; Lee KH; Smith PC
    Drug Metab Dispos; 2006 Sep; 34(9):1436-42. PubMed ID: 16751262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acyl glucuronide reactivity in perspective: biological consequences.
    Bailey MJ; Dickinson RG
    Chem Biol Interact; 2003 May; 145(2):117-37. PubMed ID: 12686489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LC-1H NMR used for determination of the elution order of S-naproxen glucuronide isomers in two isocratic reversed-phase LC-systems.
    Mortensen RW; Corcoran O; Cornett C; Sidelmann UG; Troke J; Lindon JC; Nicholson JK; Hansen SH
    J Pharm Biomed Anal; 2001 Jan; 24(3):477-85. PubMed ID: 11199227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New Perspectives on Acyl Glucuronide Risk Assessment in Drug Discovery: Investigation of In vitro Stability, In situ Reactivity, and Bioactivation.
    Gunduz M; Argikar UA; Cirello AL; Dumouchel JL
    Drug Metab Lett; 2018; 12(2):84-92. PubMed ID: 29886840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.